COMP <GO>
UNH vs ELV // FORWARD P/E MULTIPLE
UnitedHealth Group Incorporated (NYSE) VS. Elevance Health Inc. (NYSE) • 15-METRIC TALLY: UNH 7
— ELV 6
▲ FORWARD P/E MULTIPLE LEADER: ELV
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
forward-pe
17.7x
LAST: $420.07 (-0.46%) • MKT CAP: $91.18B
forward-pe
13.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UNH VS. ELV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UNH | ELV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.57% | 89.40% | -0.83 | ELV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.47% | 8.70% | +2.77 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.4x | 13.8x | +2.65 | ELV | /valuation <GO> |
| Free Cash Flow Yield | 6.48% | 3.48% | +3.00 | UNH | /fcf-yield <GO> |
| Operating Margin | 4.82% | 3.60% | +1.22 | UNH | /operating-margins <GO> |
| Net Profit Margin | 3.14% | 2.80% | +0.34 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 6.46% | 12.50% | -6.04 | ELV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.28% | 1.68% | +0.60 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.12 | 3.17 | -0.05 | ELV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.74% | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.2 | 52.0 | +7.20 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.33 | 1.07 | -0.74 | ELV | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 17.7x | 13.5x | +4.24 | ELV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $368.83B | $91.18B | $277.65B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UNH REV | ELV REV | UNH GROSS % | ELV GROSS % | UNH FCF | ELV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $447.57B | $199.13B | 88.7% | 89.4% | $16.07B | $3.17B |
| FY 2024 | $400.28B | $177.01B | 88.3% | 88.8% | $20.70B | $4.55B |
| FY 2023 | $371.62B | $171.34B | 89.6% | — | $25.68B | $350.7M |
| FY 2022 | $324.16B | — | 89.6% | — | $23.40B | — |
| FY 2021 | $287.60B | — | 89.2% | — | $19.89B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UNH // BETA 0.33
ELV // BETA 1.07